Athena Countouriotis's Net Worth
Estimate Recalculated Nov 1, 2024 02:19PM EST
Who is Athena Countouriotis
Athena Countouriotis has an estimated net worth of $19.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., IOVANCE BIOTHERAPEUTICS, INC., HALOZYME THERAPEUTICS INC, Adverum Biotechnologies, Inc., Passage BIO, Inc., Trovagene, Inc., AMBIT BIOSCIENCES CORP, and BIOMARIN PHARMACEUTICAL INC.
SEC CIK
Athena Countouriotis's CIK is 0001571469
Past Insider Trading and Trends
2021 was Athena Countouriotis's most active year for acquiring shares with 8 total transactions. Athena Countouriotis's most active month to acquire stocks was the month of January. 2021 was Athena Countouriotis's most active year for disposing of shares, totalling 17 transactions. Athena Countouriotis's most active month to dispose stocks was the month of January. 2019 saw Athena Countouriotis paying a total of $687,975.66 for 102,440 shares, this is the most they've acquired in one year. In 2022 Athena Countouriotis cashed out on 2,152,124 shares for a total of $8,540,731.30, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
